Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Clinical trial NCT02736149 · TERMINATED
Trial details
- NCT number
- NCT02736149
- Sponsor
- Eiger BioPharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-03-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.